SCHEMBL14724609

SCHEMBL14724609

CNc1ccc(C(F)(F)F)cc1NC(=O)c1cc(-c2ccc3nc(N)ncc3c2)ccc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 14/20 0.55
KDR P35968 8/20 0.49
TEK Q02763 4/20 0.49
FGFR4 P22455 1/20 0.48
BRAF P15056 1/20 0.48
EIF2AK3 Q9NZJ5 1/20 0.48
EIF2AK4 Q9P2K8 1/20 0.48
MAPK14 Q16539 6/20 0.46
JAK3 P52333 5/20 0.46
SRC P12931 2/20 0.43
TYK2 P29597 1/20 0.43
SYK P43405 1/20 0.43
BTK Q06187 1/20 0.43
MAPT P10636 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KIT P10721 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5489319 0.84 LCK (0.77) LCKKDRTEKBRAFEIF2AK3
SCHEMBL5501160 0.83 LCK (0.59) LCKKDRTEKFGFR4BRAF
SCHEMBL5497037 0.83 LCK (0.59) LCKKDRTEKFGFR4BRAF
SCHEMBL5503706 0.80 LCK (0.47) LCKKDRTEKBRAFEIF2AK3
SCHEMBL5503625 0.79 LCK (0.46) LCKKDRTEKFGFR4BRAF
SCHEMBL5495900 0.78 LCK (0.71) LCKKDRTEKBRAFMAPK14
SCHEMBL5489774 0.77 LCK (0.61) LCKKDRTEKMAPK14JAK3
SCHEMBL5498788 0.77 LCK (0.68) LCKKDRTEKMAPK14JAK3
SCHEMBL5496542 0.76 LCK (0.57) LCKKDRTEKBRAFMAPK14
SCHEMBL5502527 0.76 LCK (0.56) LCKKDRTEKFGFR4BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B1 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2013-02-27 EP disclosed